The Complete Guide
Low libido in women: what actually causes it and what works
A practical, honest guide for women dealing with persistent low desire and considering treatment options.
Low libido is a real medical condition
Hypoactive sexual desire disorder (HSDD) is the clinical name for persistent, distressing low sexual desire that is not explained by another medical condition, medication, relationship issue, or life circumstance. The distress part matters — low desire without personal distress is not a disorder, it is just a preference. HSDD is the combination of low desire AND bother about it. By that definition, roughly 1 in 10 premenopausal women meet criteria at any given time, and a significantly larger fraction of women experience meaningful low libido at some point without quite meeting the formal diagnosis.
The first thing worth saying is that low libido is rarely about willpower or love. It is usually a combination of hormonal, neurological, medication, and contextual factors. Telling a woman to 'just try harder' is about as useful as telling someone with depression to cheer up. The body and brain have specific mechanisms that regulate desire, and those mechanisms can go wrong in identifiable ways that respond to treatment.
The honest version: low libido is almost never just in your head, and it is almost never just hormones either. Most women with persistent low desire have two or three things going on at once — an antidepressant effect, sleep deprivation, relationship stress, and a hormonal shift all adding up. Treatment that helps usually addresses more than one of those at the same time.
What actually causes low libido
- Hormonal changes. Estrogen, testosterone, and progesterone all influence desire in women. Perimenopause, menopause, postpartum, and breastfeeding all involve large hormonal shifts that reduce libido in many women.
- Medications. SSRIs and SNRIs (antidepressants) are one of the most common causes of acquired low libido in women. Hormonal contraceptives can lower libido for a subset of users. Beta blockers and certain other medications contribute too.
- Sleep and stress. Chronic sleep deprivation wrecks libido through cortisol, testosterone suppression, and basic exhaustion. No medication fixes this if sleep is broken.
- Relationship dynamics. Chronic conflict, resentment, or emotional disconnection will flatten desire in ways no pill can override. Therapy for the relationship is sometimes the right first step.
- Pain or medical conditions. Dyspareunia (pain with intercourse), vaginal dryness, pelvic floor dysfunction, and underlying chronic conditions all affect desire. Vaginal estrogen resolves one of the most common underlying issues in postmenopausal women.
- Thyroid and other endocrine issues. Untreated hypothyroidism, high prolactin, and adrenal issues can all suppress libido and deserve evaluation.
A thoughtful evaluation looks at all of the above before jumping to pharmacology. Related: hormone therapy guide and perimenopause guide.
Treatments that actually have evidence
There are a few evidence-based options specifically for female low libido, plus several treatments that help indirectly by addressing contributing factors.
- Flibanserin (Addyi). The first FDA-approved medication for generalized HSDD in premenopausal women. A daily non-hormonal oral tablet taken at bedtime. Works on serotonin, dopamine, and norepinephrine receptors in the brain. Clinical trial data shows modest improvements in desire and sexually satisfying events above placebo. Has a black box warning about interaction with alcohol and certain medications. A licensed physician evaluates whether it is appropriate.
- Bremelanotide (Vyleesi). The second FDA-approved medication for HSDD in premenopausal women. A melanocortin receptor agonist administered as a subcutaneous injection at least 45 minutes before anticipated sexual activity. Not used daily. Side effects include nausea, headache, and transient blood pressure elevation.
- Testosterone for postmenopausal women. The Global Consensus Position Statement on the Use of Testosterone Therapy for Women (2019) endorses low-dose testosterone for postmenopausal women with HSDD who have not responded to other interventions. Typically prescribed off-label because there is no FDA-approved female testosterone product in the US. A licensed physician familiar with the protocol can prescribe and monitor.
- Vaginal estrogen. For postmenopausal women where pain and dryness contribute to avoidance, low-dose vaginal estrogen (cream, tablet, ring) is extremely effective and has a favorable safety profile even for women who cannot take systemic hormones.
- Addressing contributing medications. If a current medication is the contributor, a physician can discuss alternatives. Switching from an SSRI to bupropion, for example, often improves sexual side effects. Changing contraception can help some women.
What to be skeptical of
- 'Female Viagra' marketing. Sildenafil does not work the same way in women that it does in men. Clinical trials in women have generally shown disappointing results. Avoid any product marketing itself this way.
- Herbal libido boosters. Maca, horny goat weed, ginseng, tribulus, saffron — most have thin or conflicting evidence, and the supplement quality is unregulated. A few have modest evidence; most are marketing.
- Miracle protocols. Anyone selling a guaranteed fix for female low libido is selling something that doesn't exist. Treatment often works but is individualized, gradual, and usually involves addressing more than one contributor at a time.
How to get started
If you are dealing with persistent low libido that is bothering you, complete your assessment. A licensed Puri-affiliated physician will review your medical history, medications, and symptoms, and discuss evidence-based options. A prescription is not guaranteed.
